A randomized phase II trial evaluating the efficacy of a nivolumab monotherapy lead in "window" or commencement of nivolumab concurrently with paclitaxel and carboplatin as neoadjuvant therapy in early stage triple negative breast cancers (BCT 1902 Neo-N Cohorts A & B)
收藏DataCite Commons2025-03-04 更新2024-07-13 收录
下载链接：
https://doi.breastcancertrials.org.au/103
下载链接
链接失效反馈官方服务：
资源简介：
HeSANDA 1.0.0
提供机构：
Breast Cancer Trials (BCT)
创建时间：
2023-12-05
